Page last updated: 2024-10-21

3-aminobenzamide and Leprosy

3-aminobenzamide has been researched along with Leprosy in 1 studies

Leprosy: A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.

Research Excerpts

ExcerptRelevanceReference
"A marginal increase in the frequency of chromosome aberrations was observed following treatment with 3-AB in controls as well as in patient groups."1.28Effect of inhibitor of poly (ADP-ribose) polymerase in blood lymphocyte cultures of untreated leprosy patients. ( D'Souza, D; Das, BC; Thomas, IM, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
D'Souza, D1
Thomas, IM1
Das, BC1

Other Studies

1 other study available for 3-aminobenzamide and Leprosy

ArticleYear
Effect of inhibitor of poly (ADP-ribose) polymerase in blood lymphocyte cultures of untreated leprosy patients.
    Mutation research, 1992, Dec-16, Volume: 284, Issue:2

    Topics: Benzamides; Cells, Cultured; Chromosome Aberrations; DNA Repair; Humans; Leprosy; Lymphocytes; Male;

1992